Pulmonary Hypertension in Interstitial Lung Disease
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Pulmonary Arterial Hypertension
Related studies linked through entity extraction aliases.
Lidocaine Subcutaneous Infusion for Control of Treprostinil Related Site Pain
- Status
- TERMINATED
- Phase
- PHASE4
Epoprostenol for Injection (EFI/ACT-385781A) - Pulmonary Arterial Hypertension
- Status
- COMPLETED
- Phase
- PHASE3
Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
- Status
- COMPLETED
- Phase
- N/A
Registry for Pulmonary Hypertension in China
- Status
- UNKNOWN
- Phase
- N/A
Safety, Tolerability, and PK Parameters of Sodium Nitrite Inhalation Solution in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Respiratory and Physical Therapy in Patients With Associated Pulmonary Arterial Hypertension (APAH) With Congenital Heart Defects
- Status
- RECRUITING
- Phase
- NA
Extension to CQTI571A2102 to Evaluate Long-term Safety, Tolerability and Efficacy of Imatinib in Severe Pulmonary Arterial Hypertension (PAH)
- Status
- TERMINATED
- Phase
- PHASE3
Pharmacokinetic Effects of QTI571 on Sildenafil and Bosentan in Pulmonary Arterial Hypertension Participants
- Status
- COMPLETED
- Phase
- PHASE3
Responsiveness of Exercise Tests in Pulmonary Arterial Hypertension
- Status
- COMPLETED
- Phase
- NA
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
- Status
- COMPLETED
- Phase
- N/A
Effects of Iloprost Treatment in Adult Patients With Pulmonary Arterial Hypertension Related to Congenital Heart Disease
- Status
- UNKNOWN
- Phase
- N/A
Evaluate The Clinical Effectiveness, Safety And Tolerability Of Sildenafil Used In Doses ≥20mg TID For The Treatment Of Pulmonary Arterial Hypertension
- Status
- COMPLETED
- Phase
- N/A
Measuring Blood Pressure in the Lung Circulation With Sonar Technology (Echo-Doppler)
- Status
- TERMINATED
- Phase
- PHASE1
Efficacy of Ventavis Used in Real-life Setting.
- Status
- COMPLETED
- Phase
- N/A
Evaluation of Metformin Activity in Addition to Conventional Treatment of Grade II or III Pulmonary Arterial Hypertension (PAH)
- Status
- WITHDRAWN
- Phase
- PHASE2
FUTURE 3 Study Extension
- Status
- COMPLETED
- Phase
- PHASE3
Safely Change From Bosentan to Ambrisentan in Pulmonary Hypertension
- Status
- COMPLETED
- Phase
- PHASE4
DelIVery for Pulmonary Arterial Hypertension (PAH) & Continued Support Study
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Iloprost for the Treatment of Pulmonary Hypertension in Adults With Congenital Heart Disease
- Status
- TERMINATED
- Phase
- NA